Register for SOSV Climate Tech Summit – Nov 3-7, 2025 (Virtual, Free). Learn More

Wayfinder Biosciences

Unlocking the future of smart biotechnology

Team

David Sparkman-Yager

CTO

Jason Fontana

CEO

Company details

Wayfinder has built a drug discovery platform for small molecules that modulate RNA targets. Their technology generates highly quantitative data on RNA-small molecules interactions at high-throughput. Combined with their AI/ML virtual screening models, they can search billions of molecules for RNA modulators in just 3 days.

And they do it way faster than anyone else in the world. Wayfinder is WAY faster.

A spinout from the Center for Synthetic Biology at the University of Washington, Wayfinder has internal programs in oncology and unique technologies to unlock RNA drugging.

Get In Touch with Wayfinder Biosciences

Please tell us a little bit about yourself and why you'd like to get connected. Wayfinder Biosciences + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.